Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Age- and sex-stratified two-year prevalence of HD

From: Epidemiology and health care utilization of patients suffering from Huntington’s disease in Germany: real world evidence based on German claims data

 Women (n = 139)95%-CIMen (n = 169)95%-CIAll (n = 308)95%-CI
N populationn casesPrevalence per 100,000 personsN populationn casesPrevalence per 100,000 personsN populationn casesPrevalence per 100,000 persons
Age
 0–29 years426,131< 5 440,649/ 866,78060.70.3–1.5
 30–39 years173,71452.91.2–6.7172,856105.83.1–10.6346,570154.32.6–7.1
 40–49 years221,720188.15.1–12.8223,1052913.09.1–18.7444,8254710.67.9–14.0
 50–59 years284,6513813.39.7–18.3289,8134816.612.5–22.0574,4648615.012.1–18.5
 60–69 years235,6664217.813.2–24.1222,8713515.711.3–21.8458,5377716.813.4–21.0
 70–79 years193,3362412.48.3–18.5192,7993417.612.6–24.6386,1355815.011.6–19.4
 > =80 years141,03596.43.4–12.1107,292109.35.1–17.2248,327197.74.9–12.0
 All1,676,2531398.37.0–9.81,649,38516910.28.8–11.93,325,6383089.38.3–10.4
  1. CI Confidence interval